Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-19T10:39:01.877Z Has data issue: false hasContentIssue false
  • English
  • Français

Using the Brief Core Schema Scales with Individuals at Clinical High Risk of Psychosis

Published online by Cambridge University Press:  23 January 2009

Jean Addington  and
Lisa Tran
Jean Addington*
Affiliation:
Universities of Calgary and Toronto, Canada
Lisa Tran
Affiliation:
Centre for Addiction and Mental Health, Toronto, Canada
*
Reprint requests to Jean Addington, Department of Psychiatry, Health Sciences Centre, Faculty of Medicine, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: The Brief Core Schema Scales (BCSS) were developed to provide a theoretically coherent self-report assessment of schemata concerning self and others in psychosis. They provide a more useful measure of schemata about self and others than traditional measures of self-esteem. Aims: The aim of this study was to determine if these scales would be useful in a sample of individuals who are at clinical high risk of psychosis to help identify targets for intervention. Method: Thirty-eight individuals who are at high risk for psychosis were administered the Scale of Prodromal Symptoms, the Calgary Depression Scale, the Brief Core Schema Scales and the Young Schema Questionnaire–short version. Results: Results suggested that these scales are appropriate for this population and that negative evaluations of the self and others were significantly associated with attenuated psychotic symptoms and, in particular, suspiciousness.

Keywords

Clinical high riskprodromeearly psychosisBrief Core Schema Scalesschemata
Type
Brief Clinical Reports
Information
Behavioural and Cognitive Psychotherapy , Volume 37 , Issue 2 , March 2009 , pp. 227 - 231
Copyright
Copyright © British Association for Behavioural and Cognitive Psychotherapies 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, D., Addington, J., Maticka-Tyndale, E. and Joyce, J. (1992). Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research, 6, 201–208CrossRefGoogle ScholarPubMed
Addington, J., Cadenhead, K. S., Cannon, T. D., Cornblatt, B., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., Walker, E. F., Woods, S. W. and Heinssen, R. (2007). North American Prodrome Longitudinal Study (NAPLS): a collaborative multi-site approach to prodromal Schizophrenia. Schizophrenia Bulletin, 33, 665–672.CrossRefGoogle Scholar
Addington, J., Epstein, I., Reynolds, A., Furimsky, I., Rudy, L., Mancini, B., McMillan, S., Kirsopp, D. and Zipursky, R. (2008). Early detection of psychosis: finding those at clinical high risk, Journal of Early Intervention in Psychiatry, 2, 147–153.CrossRefGoogle ScholarPubMed
Fowler, D., Freeman, D., Smith, B., Kuipers, E., Bebbington, P., Bashforth, H., Coker, S., Hodgekins, J., Gracie, A., Dunn, G. and Garety, P. (2006). The Brief Core Schema Scales (BCSS): psychometric properties and associations with paranoia and grandiosity in non-clinical and psychosis samples. Psychological Medicine, 6, 749–759.CrossRefGoogle Scholar
Garety, P. A., Kuipers, E., Fowler, D., Freeman, D. and Bebbington, P. E. (2001). Theoretical paper: a cognitive model of the positive symptoms of psychosis. Psychological Medicine, 31, 189–195.CrossRefGoogle Scholar
Krabbendam, L., Myin-Germeys, I., Hanssen, M., de Graff, R., Vollebergh, W., Bak, M. and van Os, J. (2005). Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. British Journal of Clinical Psychology, 44, 113–125.CrossRefGoogle ScholarPubMed
Miller, T. J., McGlashan, T. H., Rosen, J. L., Cadenhead, K., Ventura, J., McFarlane, W., Perkins, D. O., Pearlson, G. D. and Woods, S. W. (2003)a. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin, 29, 703–715.CrossRefGoogle ScholarPubMed
Miller, T. J., Zipursky, R., Perkins, D. O., Addington, J., Woods, S. W., Hawkins, K. A., Hoffman, R., Preda, A., Epstein, I., Addington, D., Lindborg, S., Marquez, E. S., Tohen, M., Breier, A. and McGlashan, T. H. (2003)b. The PRIME North America randomized double-blind clinical trial of olanzapine vs placebo in patients at risk for being prodromally symptomatic for psychosis: II. Baseline characteristics of the “prodromal” sample. Schizophrenia Research, 61, 19–30.CrossRefGoogle Scholar
Morrison, A. P., French, P., Walford, L., Lewis, S. W., Kilcommons, A., Green, J., Parker, S. and Bentall, R. P. (2004). Cognitive therapy for the prevention of psychosis in people at ultra high risk randomized controlled trial. British Journal of Psychiatry, 185, 291–297.CrossRefGoogle Scholar
Young, J. E. (1998). The Young schema questionnaire short form (http://home.sprynet.com/spynet/schema/ysqs1.htm) Accessed 22/05/08.Google Scholar
Submit a response

Comments

No Comments have been published for this article.